VERITAS EPI

VERITAS EPI · Research platform

Epigenomic researchand molecular insight

EpigenomicsDNA methylationMolecular biologyGenomic researchBiological dataClinical researchPrecision medicineBiomedical science
Fig. 01DNA methylation landscape
β 0.0β 1.0

Illustrative visualisation of β values across CpG sites in a sample set. Conceptual figure, not clinical or patient data.

Molecular network representing epigenetic regulation
Fig. 02Molecular organisation of the epigenome, the regulatory layer studied by VERITAS EPI.
01Epigenomic science

The genome is the sequence. The epigenome regulates how it is used.

Epigenetic mechanisms regulate gene activity without altering the underlying DNA sequence. DNA methylation is one of these mechanisms, and one of the most extensively studied in aging and disease research.

Genome

The inherited genetic sequence. It does not change with environment or lifestyle.

Epigenome

A regulatory layer influencing which genes are active in which tissues.

DNA methylation

A chemical mark, typically at CpG dinucleotides, associated with gene regulation.

Aging biology

Methylation patterns shift across the lifespan and are used in research models of biological age.

Fig. 03Genome browser view, CpG island
chr6:31100kchr6:31140kchr6:31180kchr6:31220kchr6:31260kchr6:31300kchr6:31340kchr6:31380kchr6:31420kchr6:31460kCpG island

Coverage histogram, annotated CpG island and per-site methylation calls along a genomic interval. Conceptual figure.

02DNA methylation
Scientist inspecting epigenomic assay control wells

Fig. 04Analytical controls used to assess assay performance.

β values describe the methylation state of a CpG site

A β value expresses the proportion of methylated signal at a given CpG site, from 0 (unmethylated) to 1 (methylated). Across an array or sequencing panel, the distribution of these values is characteristically bimodal.

Fig. 05β value density distribution
0.0 unmethylated0.51.0 methylated

Illustrative bimodal density of β values across measured CpG sites. Conceptual figure, not clinical data.

Fig. 06Bisulfite sequencing read alignment

Filled circles denote methylated CpG calls, open circles unmethylated calls, across aligned reads. Conceptual figure.

03Molecular data

From raw signal to interpretable biological measurement

Epigenomic data passes through defined bioinformatics stages: quality control, normalisation, probe or read filtering, model application and reporting with reference information.

Quality control

Signal intensity, detection thresholds and sample-level checks.

Normalisation

Correction of technical variation between arrays, batches and runs.

Model application

Application of published or internally validated methylation models.

Reporting

Output presented with reference information, evidence level and limitations.

Fig. 07Multiomics data clustering
GENOMICEPIGENOMICTRANSCRIPTOMIC

Conceptual representation of genomic, epigenomic and transcriptomic layers analysed together in research settings.

Bioinformatics workstation displaying methylation data analysis

Fig. 08Computational analysis environment.

04Biological research

Chronological age and biological-aging measures are not the same construct

Chronological age is time since birth. Biological-aging measures are research constructs derived from molecular data, interpreted only within appropriate scientific and clinical context.

Chronological age

A number

Time since birth, measured directly.

Biological-aging measure

A model output

Derived from methylation data through a defined and referenced model.

Fluorescence microscopy image of human cells used in aging biology research

Fig. 09Fluorescence microscopy of human cells.

Research context

Factors described in the literature as associated with epigenetic patterns

These associations are reported at population level. Association is not causation, and no individual result is attributed to a single factor.

Age
Smoking
Alcohol exposure
Physical activity
Nutrition
Metabolic biology
Inflammation
Psychological stress
Environmental exposures
Disease states
Genetic background
05Clinical context

Reported domains and their required context

Only analytically and clinically validated domains are reported. Every domain carries its reference information, evidence level and limitations.

  1. DNA methylation heatmap displayed on a laboratory monitorDomain 01

    Epigenetic age

    Validated age-related metric(s), reported with the reference model applied.

  2. DNA methylation beta value density visualisationDomain 02

    Age deviation

    Difference relative to the appropriate reference model, where validated.

  3. Genome browser methylation tracks on a laboratory screenDomain 03

    Aging-related domains

    Only validated domains are displayed in a research or clinical report.

  4. Bioinformatics dashboard for genomics analysisDomain 04

    Metabolic context

    Interpreted alongside conventional metabolic measurement; it does not replace clinical testing.

  5. Multiomics visualisation of integrated molecular data layersDomain 05

    Inflammatory biology

    How inflammatory pathways intersect with aging research.

  6. Bisulfite sequencing methylation calls across aligned readsDomain 06

    Environmental factors

    Physical activity, nutrition, sleep and exposures studied in relation to aging biology.

Clinical research discussion between medical professionals

Fig. 10Interpretation takes place within a clinical setting.

Interpretation belongs to a qualified healthcare professional

Molecular measurements do not diagnose disease. They are one input among clinical history, examination and conventional laboratory investigation.

06Research methodology

Specimen to interpretation: the analytical pathway

Each stage is documented, with the sample requirement, laboratory procedure, computational step and reporting rule stated explicitly.

01

Specimen and collection

Collection of a validated biological specimen under a documented protocol.

Specimen requirements, handling, logistics and stability windows are defined for each validated specimen type.

Laboratory scientist accessioning barcoded clinical specimens
02

Nucleic acid extraction

DNA extraction and quality assessment prior to conversion.

Extraction yield and integrity are assessed against defined acceptance criteria before a sample proceeds.

Scientist performing nucleic acid extraction with automated instrumentation
03

Epigenomic analysis

Bisulfite conversion and methylation measurement across CpG sites.

Conversion efficiency and control probes are monitored as part of the analytical quality system.

Microfluidic assay and plate used for epigenomic measurement
04

Bioinformatics

Quality control, normalisation and application of referenced models.

Pipelines, model versions and reference populations are recorded for each analysis.

Medical scientist reviewing a structured statistical report
05

Interpretation and limitations

Structured reporting with evidence level, reference information and limitations.

Statements are separated into mechanistic hypothesis, association, clinical evidence and validated biomarker.

Clinician explaining a structured laboratory report to a patient
06

Validation and review

Continuous scientific review and documented validation of methods.

Analytical and clinical validation documentation is published as it is verified.

Laboratory scientist performing instrument validation with reference samples
07Precision medicine

Methodology, evidence and limitations, stated openly

Rather than comparing products, VERITAS EPI describes what is measured, how it is measured, what the evidence supports and where the limits are.

01

Analytical methodology

Specimen type, laboratory procedure, conversion chemistry, measurement platform and control strategy are documented.

02

Clinical context

Findings are placed alongside conventional clinical measurement and interpreted by a qualified professional.

03

Evidence level

Mechanistic hypothesis, association, clinical evidence and validated biomarker are reported as distinct categories.

04

Data interpretation

Reference model, reference population and model version accompany every reported measure.

05

Research limitations

Known limitations of methylation-based measures are stated in the report rather than in fine print.

06

Scientific review

Methods and reported domains are subject to continuous review as the literature develops.

Editorial rule

Affiliation, accreditation and regulatory statements are published only when the exact relationship, authorisation or certificate has been verified. Published academic work that is not a formal collaboration is described as scientific foundation or research landscape.

Scientific integrity

How this platform handles evidence

  • 01Documented scientific methodology
  • 02Clinical and medical oversight
  • 03Laboratory quality systems
  • 04Validated analytical methods
  • 05Transparent evidence grading
  • 06Data protection and consent
  • 07Professional interpretation pathway
  • 08Continuous scientific review

Questions

Frequently asked scientific questions

No. VERITAS EPI does not predict lifespan and does not estimate life expectancy. It measures epigenetic signals studied in relation to biological aging in research settings and reports them within scientific and clinical context.

No. The analysis is not a diagnostic test for any disease. It does not replace clinical history, examination or conventional laboratory investigation, and results must be interpreted by a qualified healthcare professional.

No. The analysis measures epigenetic marks, particularly DNA methylation. It does not modify DNA and does not alter the genome.

We make no claims about reversing aging. Some factors are described in the literature as associated with epigenetic patterns, but population-level association does not establish that an individual measure can be changed in a defined way.

Epigenomic information requires a high standard of protection. Data handling, storage, retention and consent are described on the Standards page and governed by the approved policies applicable to your jurisdiction.

VERITAS EPI

Epigenomic data, described with its methodology, its evidence and its limits.

This platform exists to make molecular research understandable, not to sell a number. Every statement is graded, referenced and open to scientific review.